Allianz Asset Management GmbH lifted its stake in Medical Properties Trust, Inc. (NYSE:MPW – Get Rating) by 53.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,415,023 shares of the real estate investment trust’s stock after purchasing an additional 494,522 shares during the quarter. Allianz Asset Management GmbH owned about 0.24% of Medical Properties Trust worth $33,437,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. increased its holdings in shares of Medical Properties Trust by 27.2% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 295,471 shares of the real estate investment trust’s stock valued at $6,982,000 after purchasing an additional 63,259 shares during the last quarter. Lincoln National Corp grew its position in Medical Properties Trust by 40.1% in the fourth quarter. Lincoln National Corp now owns 22,661 shares of the real estate investment trust’s stock worth $536,000 after acquiring an additional 6,491 shares during the period. Commonwealth Equity Services LLC grew its position in Medical Properties Trust by 2.5% in the fourth quarter. Commonwealth Equity Services LLC now owns 272,615 shares of the real estate investment trust’s stock worth $6,441,000 after acquiring an additional 6,760 shares during the period. BNP Paribas Arbitrage SA grew its position in Medical Properties Trust by 26.2% in the fourth quarter. BNP Paribas Arbitrage SA now owns 247,336 shares of the real estate investment trust’s stock worth $5,845,000 after acquiring an additional 51,323 shares during the period. Finally, Profund Advisors LLC grew its position in Medical Properties Trust by 62.6% in the third quarter. Profund Advisors LLC now owns 85,988 shares of the real estate investment trust’s stock worth $1,726,000 after acquiring an additional 33,101 shares during the period. 82.27% of the stock is owned by hedge funds and other institutional investors.
Several research firms have recently commented on MPW. StockNews.com began coverage on Medical Properties Trust in a research report on Thursday, March 31st. They set a “hold” rating for the company. Bank of America lowered Medical Properties Trust from a “buy” rating to a “neutral” rating and set a $21.00 price target for the company. in a research report on Friday, March 11th. Deutsche Bank Aktiengesellschaft lowered their price target on Medical Properties Trust from $25.00 to $20.00 in a research report on Wednesday, April 27th. Credit Suisse Group lowered their price target on Medical Properties Trust from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, February 14th. Finally, Truist Financial lowered their price target on Medical Properties Trust from $26.00 to $23.00 and set a “hold” rating for the company in a research report on Thursday, March 24th. Six research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Medical Properties Trust currently has a consensus rating of “Buy” and a consensus target price of $23.10.
Medical Properties Trust (NYSE:MPW – Get Rating) last posted its quarterly earnings results on Thursday, April 28th. The real estate investment trust reported $1.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.58. Medical Properties Trust had a return on equity of 13.25% and a net margin of 70.61%. The company had revenue of $409.80 million for the quarter, compared to analysts’ expectations of $413.31 million. During the same period last year, the firm earned $0.42 earnings per share. Medical Properties Trust’s quarterly revenue was up 13.0% on a year-over-year basis. On average, research analysts expect that Medical Properties Trust, Inc. will post 1.83 earnings per share for the current fiscal year.
In related news, CEO Edward K. Aldag, Jr. sold 615,000 shares of the stock in a transaction on Wednesday, March 30th. The stock was sold at an average price of $21.33, for a total transaction of $13,117,950.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Michael G. Stewart sold 6,000 shares of the stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $20.26, for a total value of $121,560.00. The disclosure for this sale can be found here. Insiders sold 906,000 shares of company stock valued at $19,235,910 over the last three months. Corporate insiders own 1.04% of the company’s stock.
Medical Properties Trust Company Profile (Get Rating)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.
- Get a free copy of the StockNews.com research report on Medical Properties Trust (MPW)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Will John Deere’s Earnings Help to Calm the Markets?
- Lowe’s Companies Has Not Bottomed
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.